Overview

TEAM-Project: Trial on the Effect of Anesthetics on Morbidity and Mortality

Status:
Completed
Trial end date:
2011-11-01
Target enrollment:
0
Participant gender:
All
Summary
Volatile anesthetics may provide some protection from myocardial ischemia, an effect called anesthetic preconditioning. In patients undergoing coronary artery bypass surgery, this preconditioning effect resulted in better cardiac performance, faster recovery and lower morbidity and mortality. The investigators will perform a prospective randomized multi-center study to compare volatile with total intravenous anesthesia in patients at a high cardiac risk who undergo major non-cardiac surgery.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
University Hospital, Basel, Switzerland
Collaborator:
Abbott
Treatments:
Anesthetics
Anesthetics, Inhalation
Anesthetics, Intravenous
Propofol
Criteria
Inclusion Criteria:

- Patients scheduled for a non-cardiac surgical procedure of high or intermediate
cardiac risk are eligible if they have documented coronary artery disease (CAD) or are
at high risk of CAD.

Exclusion Criteria:

- Ongoing medication with sulfonylurea derivatives (unless stopped ≥ 2 days before
surgery) or theophylline

- Emergency surgery

- Unstable angina pectoris

- Preoperative hemodynamic instability

- Severe hepatic disease

- Renal insufficiency (creatinine clearance < 30 ml/min)

- Severe chronic obstructive pulmonary disease (forced expiratory volume in 1 second
[FEV1] < 1 litre)

- Absence of written patient consent